TD-HB941011

Mammalian Cells

P15692-4

Met1-Arg191

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Homo sapiens (Human)

Recombinant

Please contact with the lab for this information.

>95% as determined by SDS-PAGE.

23.28 kDa

Lyophilized

Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Reconstitute in sterile water for a stock solution. Adjust the volume of sterile water so that, after reconstitution, the final stock concentration matches the value indicated on the product label or datasheet.　　RECONSTITUTION PROTOCOL　　1.　Allow the product to be reconstituted and the reconstitution diluent to reach room temperature. ２.　Tap or briefly centrifuge the product vial before opening to dislodge any lyophilized material that may be dispersed on the wall or cap of the vial. ３.　Use the diluent and stock concentration recommended in the product datasheet. If preparing a stock concentration higher than recommended, contact Technical Service. ４.　After adding the diluent, re-cap the vial and invert gently by hand or place on a slow rocking platform to allow the reconstitution diluent to coat all the surfaces inside the vial.Note: Do not mix by vortexing or by pipetting the material up and down. ５.　Allow the vial to sit at room temperature with gentle agitation for at least 15 minutes before aliquotting or using. ６.　Store the reconstituted material in single use aliquots in polypropylene or siliconized tubes. Aliquots of 10 μL or larger are recommended.

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A

SDS-PAGE for Recombinant Human VEGFA/VEGF165 Protein, C-His　|　Detects VEGFA in indirect ELISAs.,Detects BD0801 in indirect ELISAs.,Detects Dilpacimab in indirect ELISAs.,Detects Conbercept in indirect ELISAs.,Detects Human VEGFA Antibody in indirect ELISAs.,Detects Vanucizumab in indirect ELISAs.,Detected by Research Grade Ivonescimab in indirect ELISA.,Detected by Research Grade Faricimab (Catalog No.:TD-HT073016) in indirect ELISA.　|　Detected by Anti-VEGFA/VEGF165 monoclonal antibody (Catalog No.:TD-HB941056),Detected by Anti-VEGFA/VEGF165 monoclonal antibody (Catalog No.:TD-MY392307),Detected by Anti-VEGFA/VEGF165 monoclonal antibody (Catalog No.:TD-MB941013)

For research use only.